Theravance Biopharma, Inc. (TBPH)

CIK 1583107 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Theravance Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 20268-K0001104659-26-106567
Aug 25, 2026DEFA14A0001104659-26-100863
Aug 25, 20268-K0001104659-26-100860
Aug 24, 202640001961289-26-000008
Aug 24, 202640001302443-26-000012
Aug 24, 202640001966698-26-000008
Aug 24, 202640002012524-26-000008
Aug 24, 202640001898490-26-000012
Aug 21, 2026DEFM14A0001104659-26-099364
Aug 14, 2026SCHEDULE 13G/A0001013594-26-000901
Aug 14, 2026SCHEDULE 13G/A0001493152-26-038373
Aug 11, 202610-Q0001104659-26-093773
Aug 11, 2026PREM14A0001104659-26-093784
Aug 10, 20268-K0001104659-26-093066
Jul 8, 202640001877589-26-000002
Jul 1, 202640001877589-26-000001
Jun 29, 2026DEFA14A0001104659-26-078454
Jun 29, 20268-K0001104659-26-078453
Jun 23, 20268-K0001104659-26-076857
Jun 23, 202640002012524-26-000006
Jun 17, 202640001898490-26-000010
Jun 16, 202640001833453-26-000006
Jun 16, 202640001270734-26-000004
Jun 16, 202640001199297-26-000003
Jun 16, 202640001625377-26-000004